Dihexa was synthesized as a small molecule compound that, in in vitro studies, demonstrated its ability to induce spinogenesis and synaptogenesis at picomolar concentrations
There are clearly observable patterns: doses that keep appearing across unrelated users, cycle lengths that cluster around specific injury types, and timing decisions that reflect real physiological consistency
Shaking creates foam and introduces shear forces that can break peptide bonds
It is not a drug, dietary supplement, or product intended for human or animal consumption.
Approximately 20 to 30 percent of users report minimal or no benefit from BPC-157
Identified by CAS 62568-57-4, DSIP has been referenced in neuroscience and molecular biology studies exploring circadian rhythm signaling, neuroendocrine communication, and adaptive stress responses